Levoleucovorin
Showing 1 - 25 of 648
Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)
Not yet recruiting
- Locally Advanced Unresectable or Metastatic Esophageal Cancer
- Futibatinib
- +6 more
- (no location specified)
Jul 6, 2023
Colorectal Tumors, Tumor Metastasis, Colonic Tumors Trial in Seoul (Atezolizumab, Bevacizumab, Oxaliplatin)
Active, not recruiting
- Colorectal Neoplasms
- +3 more
- Atezolizumab
- +4 more
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 6, 2022
Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Language Disorders
- Levoleucovorin Calcium
- Placebo
-
Phoenix, Arizona
- +1 more
Sep 26, 2022
Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Language Disorders
- Levoleucovorin Calcium
- Placebo
-
Phoenix, Arizona
- +1 more
Oct 7, 2022
Colonic Tumors Trial in Gothenburg (6R-MTHF (arfolitixorin) 200 mg/m2, Levoleucovorin 200 mg/m2, 6R-MTHF (arfolitixorin) 60
Completed
- Colonic Neoplasms
- 6R-MTHF (arfolitixorin) 200 mg/m2
- +3 more
-
Gothenburg, SwedenSahlgrenska University Hospital
Sep 7, 2020
Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +
Recruiting
- Colorectal Cancer
- +4 more
- NUC-3373 + leucovorin
- +8 more
-
Boston, Massachusetts
- +9 more
Jan 23, 2023
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- oxaliplatin
- +5 more
-
Fairfield, Connecticut
- +8 more
Oct 31, 2022
Colon Cancer Stage III Trial in Daejeon (FOLFOXIRI, mFOLFOX 6)
Recruiting
- Colon Cancer Stage III
- FOLFOXIRI
- mFOLFOX 6
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Dec 17, 2021
Rectal Cancer Trial in Korea, Republic of (radiation, drug, procedure)
Recruiting
- Rectal Cancer
- short-course radiotherapy
- +3 more
-
Daegu, Korea, Republic of
- +8 more
Jan 8, 2023
First-line Treatment of Advanced Pancreatic Cancer Trial (HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate,
Not yet recruiting
- First-line Treatment of Advanced Pancreatic Cancer
- HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
- nab-paclitaxel; gemcitabine
- (no location specified)
Feb 28, 2023
Colorectal Cancer Metastatic Trial in Vejle (drug, dietary supplement, other)
Recruiting
- Colorectal Cancer Metastatic
- Fluorouracil
- +6 more
-
Vejle, DenmarkDepartment of Oncology, Vejle Hospital
Nov 17, 2022
NSCLC, Mesothelioma, Thymoma Trial in Breda, Dordrecht (Folinic acid)
Recruiting
- NSCLC
- +2 more
- Folinic acid
-
Breda, Noord Brabant, Netherlands
- +1 more
Aug 17, 2023
Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- +2 more
- pembrolizumab
- +7 more
-
Long Beach, California
- +158 more
Jan 19, 2023
Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Cisplatin)
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- Pembrolizumab
- +7 more
-
Louisville, Kentucky
- +91 more
Mar 30, 2022
Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))
Active, not recruiting
- Metastatic Colorectal Cancer
- Aflibercept
- +4 more
-
Madrid, SpainSpanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- NP137
- +4 more
- (no location specified)
Sep 23, 2022
Colorectal Cancer, Metastatic Cancer Trial in New Brunswick, New York (FOLFOX regimen, dexamethasone, floxuridine)
Active, not recruiting
- Colorectal Cancer
- Metastatic Cancer
- FOLFOX regimen
- +7 more
-
New Brunswick, New Jersey
- +1 more
Jul 1, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC
Recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- +7 more
- Gemcitabine Hydrochloride
- +8 more
-
Philadelphia, Pennsylvania
- +1 more
Dec 20, 2022